China's original anticancer drug was approved by the US FDA for breakthrough therapy
2024-05-17 02:07:02
Medical Network January 22, January 15th, the US FDA granted China's original research drug Zanubrutinib breakthrough therapy identification, this determination will help accelerate the development and review process of Zanubrutinib, also represents the FDA on this research drug Affirmation.
Zanubrutinib is a Bruton's tyrosine kinase (BTK) inhibitor for the treatment of relapsed adult mantle cell lymphoma (MCL) patients. FDA breakthrough therapy means that data from the Zanubrutinib clinical trials show that it can significantly improve treatment outcomes compared to existing treatments. The Zanubrutinib clinical trial was led by Peking University Cancer Hospital , and Professor Zhu Jun was the main investigator.
In recent years, with the strong support of the national policy level, domestic new research drugs are increasing, and frequently appear in various occasions at home and abroad, but the number of drugs that can be approved by the FDA is limited. The clinical data of Zanubrutinib led by Peking University Cancer Hospital is informative and reliable, and the results are inspiring. This is also a great leap from the creation of new Chinese medicines from China to China. (Xu Yanshuang Liu Weiping)
Organic shiitake mushroom extract powder is extracted from the organic mushroom fruiting body. In the extraction process, the solvent selected is water or organic ethanol. The active ingredient of the mushroom extract is lentinan, which enhances cellular immunity, inhibits the growth of cancer cells, and is rich in fatty acids, which effectively lowers blood sugar in the body.
Shiitake Extract,Organic Shiitake Mushroom Extract Powder,Shiitake Mushroom Extract Powder,Shiitake Mushroom Extract
Organicway (xi'an) Food Ingredients Inc. , https://www.organicwayince.com